NEBİ ACAR, İSMAİL HASIRCI
Acta Haematologica Oncologica Turcica - 2025;58(1):58-60
Acquired hemophilia A (AHA) is a rare bleeding disorder. It is caused by autoantibodies produced against endogenous coagulation factors, without a family history of hemophilia. The incidence has been reported as 1.4 per million. The patients we see in the clinic are similar to those with hemophilia A and have a serious risk of bleeding, especially soft tissue, gastrointestinal, or mucocutaneous bleeding. The most important complication in hemophilia A cases is inhibitor development. Bypassing agents are the first choice in the treatment of AHA. In this case report, we present a patient who developed AHA after periampullary surgery.
